Skip to content
August 13, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Surgery and Reconstruction
  • Redefining Rejuvenation: The New Frontier of Combined Facial Plastic Surgery
  • Breast Cancer Surgery and Reconstruction

Redefining Rejuvenation: The New Frontier of Combined Facial Plastic Surgery

Evan Lee Salim August 13, 2026 8 minutes read
redefining-rejuvenation-the-new-frontier-of-combined-facial-plastic-surgery

In the rapidly evolving world of aesthetic medicine, the traditional "facelift" is undergoing a significant transformation. For decades, surgical intervention focused primarily on the structural repositioning of underlying tissues to address sagging and laxity. However, a groundbreaking study published in the July issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), suggests that a more holistic, multi-modal approach—integrating surgical lifting with advanced plasma skin resurfacing and regenerative medicine—may offer superior, long-lasting outcomes for patients.

The study, led by Dr. Melinda Lacerna Kimbrell of LA Plastic Surgery in Bradenton, Florida, challenges the conventional wisdom that surgical lifting and skin resurfacing should be performed as separate, staged procedures. By combining these modalities, surgeons can now address the multiple dimensions of aging simultaneously, providing a "one-stop" solution that yields measurable improvements in skin quality, volume, and structural integrity.

The Multi-Dimensional Nature of Facial Aging

To understand the necessity of this combined approach, one must first recognize that facial aging is rarely a single-issue phenomenon. As the human face matures, it experiences a trifecta of degradation: gravitational descent of soft tissues, loss of subcutaneous fat (volume depletion), and cumulative damage to the skin’s surface due to environmental factors like ultraviolet radiation and oxidative stress.

Traditional facelift (rhytidectomy) and neck lift procedures are highly effective at correcting the gravitational descent by tightening the superficial musculoaponeurotic system (SMAS) and removing excess skin. However, as Dr. Lacerna Kimbrell notes, "Facelifts alone do not address the skin aging. Facelifts alone do not address volume loss." A patient might emerge from surgery with a tightened jawline, yet still possess sun-damaged, thin, or wrinkled skin that betray their age. This realization has driven a segment of the plastic surgery community toward a more integrative paradigm.

A Chronology of Clinical Evolution: From Surgery to Synergy

The path to this combined protocol has been marked by a transition from conservative surgery to advanced biological integration.

  • The Era of Separation: Historically, plastic surgeons often deferred deep skin resurfacing—such as chemical peels or aggressive laser treatments—to a later date following a facelift. This caution was primarily rooted in concerns regarding blood supply. Surgeons feared that by undermining the skin during a lift, the additional trauma of a deep resurfacing procedure could compromise vascularity, potentially leading to necrosis or delayed healing.
  • The Rise of Regenerative Medicine: Over the past decade, the integration of fat grafting has revolutionized facial surgery. By harvesting a patient’s own adipose tissue and re-injecting it into the face, surgeons can restore youthful contours. This also introduced the concept of "nanofat" and regenerative cellular therapy, which provides a rich source of growth factors to improve skin health from the inside out.
  • The Plasma Breakthrough: The development of sophisticated helium and nitrogen plasma devices allowed for precise, controlled thermal energy delivery to the skin’s surface. Unlike some legacy lasers that carry higher risks for hyperpigmentation in darker skin tones, modern plasma devices offer a level of safety and precision that makes them viable candidates for integration with surgical lifts.
  • The Current Protocol: The recent study represents the culmination of these advancements. By performing a face and neck lift, full-face fat grafting, and plasma skin resurfacing in a single operation, surgeons are leveraging the biological benefits of the body’s healing response to optimize recovery and aesthetic results.

Supporting Data: The Case Series of 96 Patients

The study authored by Dr. Lacerna Kimbrell offers a robust look at 96 patients who underwent this multifaceted treatment plan. The protocol was meticulous: patients received a surgical lift to address deep tissue, followed by full-face fat grafting to restore volume, and deep plasma resurfacing to tighten and rejuvenate the surface. Furthermore, the protocol was bolstered by the use of topical regenerative agents, including nanofat cream and exosomes, which are gaining significant traction for their ability to accelerate cellular repair and reduce post-operative inflammation.

The objective metrics of the study were striking. Using pre- and post-operative scans to determine "skin age," the researchers documented significant physiological improvements:

  • A four-year reduction in perceived skin age.
  • A nearly 10-year improvement in skin elasticity.
  • A seven-year improvement in the appearance of fine lines and wrinkles.

Perhaps most significantly for the medical community, the study addressed the primary concern of safety. By monitoring the cohort for complications, the researchers found that the combined approach did not lead to an increased incidence of adverse events compared to traditional, singular procedures. This finding serves as a potential paradigm shift, providing surgeons with the data needed to offer this "all-in-one" experience to their patients with increased confidence.

Official Responses and Expert Perspective

The implications of these findings have resonated throughout the plastic surgery community. "There is something synergistic when we use them at the same time, when we’re healing both underneath the skin with the facelift and on top of the skin from resurfacing," says Dr. Lacerna Kimbrell.

She emphasizes that the "secret sauce" of this approach is not merely the surgical technique, but the regenerative component. "I would not do this without regenerative medicine," she stated, underscoring the critical role that fat grafting and exosome therapy play in the healing process. By providing the skin with the biological building blocks it needs while it is already in a state of repair from the surgery, the body can capitalize on a heightened metabolic state to produce better-quality tissue.

Regarding the safety of plasma resurfacing across different demographics, Dr. Lacerna Kimbrell notes that customization is paramount. By utilizing either low-intensity helium or nitrogen plasma devices based on the patient’s specific skin tone (Fitzpatrick scale), the risks of scarring or post-inflammatory pigment changes are significantly mitigated.

Implications for the Future of Aesthetic Care

The shift toward combined procedures holds profound implications for both the surgeon and the patient.

For the Patient

The most immediate benefit is efficiency. By consolidating multiple treatments into a single surgical session, patients benefit from:

  1. Reduced Anesthesia Time: Less time spent under general or twilight sedation reduces the physiological burden on the body.
  2. Simplified Recovery: While the recovery from a combined procedure may be intensive, it is a singular, focused period of downtime rather than multiple, disconnected recovery cycles for surgery, peels, and volume restoration.
  3. Cost-Effectiveness: While the upfront cost is higher than a standard facelift, the consolidation of facility fees, anesthesia costs, and surgeon fees often makes the combined approach more economical than undergoing separate, staged procedures over several years.

For the Surgeon and the Industry

The success of this study invites a broader discussion on the future of "total face rejuvenation." The medical industry is moving away from the "silo" mentality of treating only the muscle or only the skin. Instead, the focus is shifting toward biological optimization.

However, researchers are careful to note that this is a starting point, not the final word. The study explicitly calls for further investigation into new FDA-approved "cool" plasma devices and longitudinal studies that track patient satisfaction over a five-to-ten-year period. As regenerative medicine continues to evolve, the integration of stem-cell-derived therapies and more targeted topical applications will likely become standard protocol in the operating room.

Conclusion

The findings from the July issue of Plastic and Reconstructive Surgery® mark a significant evolution in how we approach facial rejuvenation. By viewing the face as a complex, multi-layered organ—requiring structural support, volume replacement, and surface restoration—surgeons can achieve results that were previously difficult to attain through surgery alone.

As the industry continues to refine these combined techniques, the focus will remain on safety, personalization, and the integration of regenerative science. For the patient, this means the prospect of a more comprehensive, efficient, and scientifically supported journey toward a refreshed appearance. As Dr. Lacerna Kimbrell’s work demonstrates, when we treat the face as a whole, the results are far greater than the sum of their parts.


About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. With a deep commitment to providing expert solutions that combine domain knowledge with specialized technology, the organization helps customers make critical decisions every day. Serving over 180 countries with a dedicated team of 20,000 professionals, Wolters Kluwer remains at the forefront of supporting clinical research and medical progress worldwide.

About the Author

Evan Lee Salim

Author

View All Posts

Post navigation

Previous: Advancing Vascular Intervention: Vesalio Secures FDA Clearance for Next-Generation pVasc NET Thrombectomy Device
Next: Beyond the "All Clear": A New Era for Breast Cancer Survivorship in Canada

Related Stories

beyond-wrinkles-the-emerging-frontier-of-botox-in-scar-prevention-and-aesthetic-healing
  • Breast Cancer Surgery and Reconstruction

Beyond Wrinkles: The Emerging Frontier of Botox in Scar Prevention and Aesthetic Healing

Reynand Wu August 13, 2026
the-invisible-feature-how-eye-tracking-technology-is-redefining-facial-aesthetics-and-rhinoplasty
  • Breast Cancer Surgery and Reconstruction

The Invisible Feature: How Eye-Tracking Technology is Redefining Facial Aesthetics and Rhinoplasty

Asro August 11, 2026
beyond-the-limits-exploring-the-historic-first-combined-face-and-whole-eye-transplant
  • Breast Cancer Surgery and Reconstruction

Beyond the Limits: Exploring the Historic First Combined Face and Whole Eye Transplant

Sagoh August 11, 2026

Recent Posts

  • PTC Therapeutics’ Strategic Bet: The Acquisition of Sangamo’s Gene Therapy Asset Amidst Bankruptcy
  • Navigating the Information Crisis: Public Perception, Regulatory Challenges, and the Rise of AI-Driven Health Misinformation
  • Advocacy in Crisis: METAvivor Challenges Proposed Rescission of Vital PCORI Research Funding
  • Every Day is Christmas: How One Veteran’s Journey Through Esophageal Cancer Redefined the Meaning of Life
  • From Compliance to Clinical Intelligence: How ConcertAI is Revolutionizing CancerLinQ

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

ptc-therapeutics-strategic-bet-the-acquisition-of-sangamos-gene-therapy-asset-amidst-bankruptcy
  • Chemotherapy and Targeted Therapy

PTC Therapeutics’ Strategic Bet: The Acquisition of Sangamo’s Gene Therapy Asset Amidst Bankruptcy

Ali Ikhwan August 13, 2026
navigating-the-information-crisis-public-perception-regulatory-challenges-and-the-rise-of-ai-driven-health-misinformation
  • Breast Cancer Legislation and Policy

Navigating the Information Crisis: Public Perception, Regulatory Challenges, and the Rise of AI-Driven Health Misinformation

Pevita Pearce August 13, 2026
advocacy-in-crisis-metavivor-challenges-proposed-rescission-of-vital-pcori-research-funding
  • Metastatic Breast Cancer Research

Advocacy in Crisis: METAvivor Challenges Proposed Rescission of Vital PCORI Research Funding

Nana Wu August 13, 2026
every-day-is-christmas-how-one-veterans-journey-through-esophageal-cancer-redefined-the-meaning-of-life
  • Psychosocial Support and Mental Health

Every Day is Christmas: How One Veteran’s Journey Through Esophageal Cancer Redefined the Meaning of Life

Laily UPN August 13, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.